Sean Bevick
Vice President, Investor Relations
Replay available
Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call
Quest Diagnostics Incorporated (NYSE: DGX) Q1 2025 earnings conference call, held 2025-04-22. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jim Davis
Chairman, Chief Executive Officer and President
Sam Samad
Chief Financial Officer
Luke Sergot
Analyst, Barclays
Kevin Caliendo
Analyst, UBS
Patrick Donnelly
Analyst, Citi
Elizabeth Anderson
Analyst, Evercore ISI
Michael Cherney
Analyst, Lyric Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Quest Diagnostics Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.516 A rebroadcast of this call in any form without written consent of Quest Diagnostics 00:00:05.516 -- 00:00:07.398 is strictly prohibited. 00:00:07.398 -- 00:00:11.622 Now I'd like to introduce Sean Bevick, Vice President and Investor Relations for Quest 00:00:11.622 -- 00:00:15.003 Diagnostics. Please go ahead. 00:00:15.445 -- 00:00:20.250 Thank you and good morning. I'm joined by Jim Davis, our Chairman, Chief Executive Officer 00:00:20.250 -- 00:00:23.793 and President, and Sam Samad, our Chief Financial Officer. 00:00:23.793 -- 00:00:28.702 During this call, we may make forward-looking statements and we'll discuss non-GAAP measures. 00:00:28.702 -- 00:00:33.326 We provide a reconciliation of non-GAAP measures to comparable GAAP measures in the tables 00:00:33.326 -- 00:00:39.593 to our earnings press release. Any actual results may differ materially from those projected. 00:00:39.593 -- 00:00:43.837 Risks and uncertainties that may affect Quest Diagnostics' future results include, but 00:00:43.837 -- 00:00:49.602 are not limited to, those described in our most recent annual report on Form 10-K 00:00:49.602 -- 00:00:54.787 and subsequently filed quarterly reports on Form 10-Q and current reports on Form 00:00:54.787 -- 00:00:56.495 8-K. 00:00:56.495 -- 00:01:01.540 For this call, references to reported EPS refer to reported diluted EPS, 00:01:01.540 -- 00:01:06.584 and references to adjusted EPS refer to adjusted diluted EPS. 00:01:06.584 -- 00:01:10.548 Growth rates associated with our long-term outlook projections, including consolidated 00:01:10.548 -- 00:01:15.332 revenue growth, revenue growth from acquisitions, organic revenue growth, and adjusted 00:01:15.332 -- 00:01:18.916 earnings growth, are compound annual growth rates...